We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

YM BioSciences Announces FDA Clearance for Phase II Nimotuzumab Trials into USA

News   Jan 27, 2010

 
YM BioSciences Announces FDA Clearance for Phase II Nimotuzumab Trials into USA
 
 
 

RELATED ARTICLES

Limitations of Health Reports From Direct-to-Consumer Genetic Tests Are Identified

News

According to study findings presented at the American Society of Human Genetics (ASHG) 2019 Annual Meeting, health reports from direct-to-consumer (DTC) genetic tests that adopt a limited variant screening approach are producing clinically false-negative results.

READ MORE

Time To Say Goodbye… to the “Household Measure” BMI?

News

A new study published in PLOS Biology sees an international collaboration of academia and industry experts introduce a novel "revolutionary" approach towards personalized and precision biomedicine, moving away from the "classic" morphometric BMI.

READ MORE

A Third "Short Sleep" Gene Has Been Discovered – And It Prevents Memory Deficits

News

In a new study, scientists have discovered a third "short sleep" gene. It is the first gene to be identified that prevents the memory deficits typically associated with sleep deprivation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE